Il semble qu'il y ait eu une erreur en essayant de charger cette page.
Notre équipe a été informée mais veuillez nous contacter en utilisant le widget support email si le problème persiste.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | No |
Is asset turnover increasing? | No | No |
Is equity multiplier increasing? | No | No |
Competitors Used |
---|
WuXi AppTec Co., Ltd. |
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. |
Maccura Biotechnology Co.Ltd |
Shanghai Runda Medical Technology Co., Ltd. |
Pharmaron Beijing Co., Ltd. |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
603,259 | 688,621 | 300,463 | 603,108 | 300,759 | 300,347 | |||
Return On Equity | ||||||||
Latest Twelve Months | 20% | 17% | 5% | 1% | 15% | 2% | ||
Fiscal Year - 1 | 16% | 19% | 13% | 11% | 13% | 10% | ||
Fiscal Year - 2 | 21% | 19% | 24% | 11% | 17% | 11% | ||
Fiscal Year - 3 | 14% | 22% | 23% | 11% | 14% | 17% | ||
Fiscal Year - 4 | 12% | 47% | 18% | 12% | 11% | 17% | ||
Fiscal Year - 5 | 11% | 49% | 17% | 11% | 15% | 24% | ||
Average | 16% | 29% | 17% | 10% | 14% | 13% | ||
Median | 15% | 21% | 18% | 11% | 14% | 14% | ||
Benchmarks | Ticker | |||||||
WuXi AppTec Co., Ltd. | SHSE:603259 | |||||||
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. | SHSE:688621 | |||||||
Maccura Biotechnology Co.Ltd | SZSE:300463 | |||||||
Shanghai Runda Medical Technology Co., Ltd. | SHSE:603108 | |||||||
Pharmaron Beijing Co., Ltd. | SZSE:300759 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | Aug-51 | May-85 | Aug-22 | Apr-51 | Jun-23 | Apr-22 | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-23 | Dec-23 | Dec-23 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Sep-24 | Sep-24 | Sep-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 37,918 | 1,078 | 2,728 | 8,433 | 11,795 | 6,603 | ||
Fiscal Year | 37,918 | 1,078 | 2,896 | 9,147 | 11,538 | 6,603 | ||
Fiscal Year - 1 | 38,678 | 932 | 3,608 | 10,494 | 10,266 | 7,384 | ||
Fiscal Year - 2 | 39,355 | 677 | 3,981 | 8,860 | 7,444 | 7,085 | ||
Fiscal Year - 3 | 22,902 | 494 | 3,704 | 7,069 | 5,134 | 5,214 | ||
Fiscal Year - 4 | 16,535 | 347 | 3,223 | 7,052 | 3,757 | 3,192 | ||
Fiscal Year - 5 | 12,872 | 234 | 2,685 | 5,964 | 2,908 | 2,803 | ||
Net Income | ||||||||
Latest Twelve Months | 11,300 | 180 | 325 | 40 | 1,884 | 405 | ||
Fiscal Year | 11,300 | 180 | 313 | 273 | 1,601 | 405 | ||
Fiscal Year - 1 | 7,944 | 185 | 708 | 418 | 1,375 | 2,025 | ||
Fiscal Year - 2 | 8,814 | 156 | 957 | 380 | 1,661 | 2,007 | ||
Fiscal Year - 3 | 5,097 | 106 | 794 | 330 | 1,172 | 2,874 | ||
Fiscal Year - 4 | 2,960 | 72 | 525 | 310 | 547 | 1,750 | ||
Fiscal Year - 5 | 1,851 | 47 | 445 | 262 | 333 | 842 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 73,669 | 1,863 | 8,233 | 14,565 | 22,476 | 29,681 | ||
Latest Fiscal Quarter | 80,326 | NA | 8,206 | 14,361 | 23,570 | 28,671 | ||
Fiscal Year | 80,326 | NA | 8,119 | 14,310 | 26,477 | 28,671 | ||
Fiscal Year - 1 | 73,669 | 1,863 | 8,168 | 14,519 | 20,493 | 29,681 | ||
Fiscal Year - 2 | 64,690 | 1,464 | 6,567 | 12,017 | 18,389 | 27,447 | ||
Fiscal Year - 3 | 55,127 | 1,243 | 6,365 | 10,177 | 11,909 | 23,741 | ||
Fiscal Year - 4 | 46,291 | 385 | 5,497 | 9,033 | 9,935 | 19,506 | ||
Fiscal Year - 5 | 29,239 | 286 | 4,556 | 7,543 | 4,801 | 7,533 | ||
Fiscal Year - 6 | 22,667 | 201 | 3,583 | 7,125 | 3,919 | 4,280 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 55,122 | 1,040 | 6,334 | 4,082 | 11,905 | 21,027 | ||
Latest Fiscal Quarter | 58,633 | 1,131 | 6,535 | 4,291 | 13,387 | 20,671 | ||
Fiscal Year | 58,633 | 1,131 | 6,385 | 4,280 | 12,557 | 20,671 | ||
Fiscal Year - 1 | 55,122 | 1,040 | 6,293 | 3,888 | 10,549 | 21,027 | ||
Fiscal Year - 2 | 46,590 | 897 | 4,299 | 3,463 | 10,129 | 19,583 | ||
Fiscal Year - 3 | 38,492 | 762 | 3,797 | 3,203 | 8,870 | 18,124 | ||
Fiscal Year - 4 | 32,494 | 189 | 3,126 | 2,758 | 7,767 | 16,119 | ||
Fiscal Year - 5 | 17,312 | 117 | 2,695 | 2,506 | 2,313 | 4,225 | ||
Fiscal Year - 6 | 17,688 | 75 | 2,501 | 2,287 | 1,998 | 2,669 |